Jacob K. Jensen

421 total citations
21 papers, 310 citations indexed

About

Jacob K. Jensen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Jacob K. Jensen has authored 21 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Jacob K. Jensen's work include Connective tissue disorders research (4 papers), Cardiovascular Function and Risk Factors (4 papers) and Tendon Structure and Treatment (4 papers). Jacob K. Jensen is often cited by papers focused on Connective tissue disorders research (4 papers), Cardiovascular Function and Risk Factors (4 papers) and Tendon Structure and Treatment (4 papers). Jacob K. Jensen collaborates with scholars based in Denmark, United States and Australia. Jacob K. Jensen's co-authors include Andreas Kjær, R Ripa, Peter Schjerling, Michael Kjær, Katja M. Heinemeier, Tina Binderup, Viktor Rotbain Curovic, Lars Holm, Emilie H. Zobel and Tine W. Hansen and has published in prestigious journals such as Journal of the American College of Cardiology, The FASEB Journal and Journal of Applied Physiology.

In The Last Decade

Jacob K. Jensen

19 papers receiving 308 citations

Peers

Jacob K. Jensen
Luke A. Beggs United States
Abigail R. Dowling United States
Sirish Maddali United States
Xin Qi China
Jacob K. Jensen
Citations per year, relative to Jacob K. Jensen Jacob K. Jensen (= 1×) peers Minoru Matsumoto

Countries citing papers authored by Jacob K. Jensen

Since Specialization
Citations

This map shows the geographic impact of Jacob K. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob K. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob K. Jensen more than expected).

Fields of papers citing papers by Jacob K. Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob K. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob K. Jensen. The network helps show where Jacob K. Jensen may publish in the future.

Co-authorship network of co-authors of Jacob K. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob K. Jensen. A scholar is included among the top collaborators of Jacob K. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob K. Jensen. Jacob K. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicolaisen, Trine S., Kim A. Sjøberg, Christian T. Voldstedlund, et al.. (2025). Dietary protein restriction elevates FGF21 levels and energy requirements to maintain body weight in lean men. Nature Metabolism. 7(3). 602–616. 6 indexed citations
2.
Bang, Lia E., Jacob K. Jensen, Lorenz Räber, et al.. (2024). ALIROCUMAB TREATMENT WAS ASSOCIATED WITH DECREASED CAROTID INFLAMMATION BY FDG-PET IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. 83(13). 1236–1236.
3.
Jensen, Jacob K., Lars Ringgaard, Bjarke Follin, et al.. (2023). [68Ga]Ga-NODAGA-E[(cRGDyK)]2 angiogenesis PET following myocardial infarction in an experimental rat model predicts cardiac functional parameters and development of heart failure. Journal of Nuclear Cardiology. 30(5). 2073–2084. 7 indexed citations
4.
Follin, Bjarke, Ingrid Hunter, Morten Juhl, et al.. (2023). [68Ga]Ga-NODAGA-E[(cRGDyK)]2 and [64Cu]Cu-DOTATATE PET Predict Improvement in Ischemic Cardiomyopathy. Diagnostics. 13(2). 268–268. 1 indexed citations
5.
Jensen, Jacob K., et al.. (2022). [64Cu]Cu-DOTATATE PET metrics in the investigation of atherosclerotic inflammation in humans. Journal of Nuclear Cardiology. 30(3). 986–1000. 6 indexed citations
6.
Jensen, Jacob K., et al.. (2022). Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis. Atherosclerosis. 352. 88–95. 30 indexed citations
7.
Jensen, Malte, Andreas Clemmensen, Jacob K. Jensen, et al.. (2022). Feasibility of positron range correction in 82-Rubidium cardiac PET/CT. EJNMMI Physics. 9(1). 51–51. 4 indexed citations
8.
Zobel, Emilie H., Christian Stevns Hansen, R Ripa, et al.. (2022). The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double‐blinded, placebo‐controlled trial. Diabetes Obesity and Metabolism. 24(8). 1638–1642. 2 indexed citations
9.
Ripa, R, Emilie H. Zobel, Bernt Johan von Scholten, et al.. (2021). Effect of Liraglutide on Arterial Inflammation Assessed as [ 18 F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial. Circulation Cardiovascular Imaging. 14(7). e012174–e012174. 33 indexed citations
10.
Zobel, Emilie H., R Ripa, Bernt Johan von Scholten, et al.. (2021). Liraglutide reduces cardiac adipose tissue in type 2 diabetes: A secondary analysis of the LIRAFLAME randomized placebo‐controlled trial. Diabetes Obesity and Metabolism. 23(12). 2651–2659. 10 indexed citations
11.
Jensen, Jacob K., Emilie H. Zobel, Bernt Johan von Scholten, et al.. (2021). Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial. Frontiers in Endocrinology. 12. 790405–790405. 28 indexed citations
12.
Jensen, Jacob K., et al.. (2020). The GLP-1 receptor agonist Semaglutide decreases vascular inflammation in a rabbit model of advanced atherosclerosis. European Heart Journal. 41(Supplement_2).
13.
Jensen, Jacob K., Rie Nygaard, René B. Svensson, et al.. (2018). Biomechanical properties of the patellar tendon in children with heritable connective tissue disorders. European Journal of Applied Physiology. 118(7). 1301–1307. 2 indexed citations
14.
Agergaard, Jakob, Jacob Bülow, Jacob K. Jensen, et al.. (2017). Effect of light-load resistance exercise on postprandial amino acid transporter expression in elderly men. Physiological Reports. 5(18). e13444–e13444. 14 indexed citations
15.
Nygaard, Rie, Jacob K. Jensen, Nicol C. Voermans, et al.. (2017). Skeletal muscle morphology, protein synthesis, and gene expression in Ehlers-Danlos syndrome. Journal of Applied Physiology. 123(2). 482–488. 3 indexed citations
16.
Agergaard, Jakob, Jacob Bülow, Jacob K. Jensen, et al.. (2016). Light-load resistance exercise increases muscle protein synthesis and hypertrophy signaling in elderly men. American Journal of Physiology-Endocrinology and Metabolism. 312(4). E326–E338. 34 indexed citations
17.
Heinemeier, Katja M., Jacob K. Jensen, Peter Schjerling, et al.. (2016). Local trauma in human patellar tendon leads to widespread changes in the tendon gene expression. Journal of Applied Physiology. 120(9). 1000–1010. 22 indexed citations
18.
Nielsen, Rie Harboe, Lars Holm, Jacob K. Jensen, et al.. (2014). Tendon protein synthesis rate in classic Ehlers-Danlos patients can be stimulated with insulin-like growth factor-I. Journal of Applied Physiology. 117(7). 694–698. 13 indexed citations
19.
Nielsen, Rie Harboe, Christian Couppé, Jacob K. Jensen, et al.. (2014). Low tendon stiffness and abnormal ultrastructure distinguish classic Ehlers‐Danlos syndrome from benign joint hypermobility syndrome in patients. The FASEB Journal. 28(11). 4668–4676. 45 indexed citations
20.
Sjödin, Anders, Christoph Gasteyger, Anne Raben, et al.. (2010). The effect of the triple monoamine reuptake inhibitor tesofensine on energy metabolism and appetite in overweight and moderately obese men. International Journal of Obesity. 34(11). 1634–1643. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026